Skip to main content
Erschienen in: Wiener klinische Wochenschrift 13-14/2013

01.07.2013 | original article

Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture

verfasst von: Claudia Friedl, Margit Hemetsberger, Julia Mader, Astrid Fahrleitner-Pammer, Thomas R. Pieber, Alexander R. Rosenkranz

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2013

Einloggen, um Zugang zu erhalten

Summary

Background

The prevalence of chronic kidney disease (CKD) is rising at an alarming rate, thus presenting a substantial burden for the patient as an individual and—because of the enormous treatment costs—for society as a whole. Early diagnosis and therapy could slow disease progression and reduce the prevalence of cost-intensive end stage renal disease. The aim of this study was to determine the accuracy of diagnosis of CKD in acute patients presenting at an internal ward.

Methods

Routine laboratory parameters of kidney function of 238 inpatients were retrospectively evaluated to determine the prevalence of CKD, defined as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2. Those results were compared with the actual documentation of the ICD-10 diagnosis CKD in the discharge reports of the respective patients.

Results

Of 238 patients, 228 patients were included in the analysis. The overall median (range) eGFR was 60.7 (10.4–171.9) mL/min/1.73 m2, with no gender-specific difference. Of patients, 49.6 % (n = 113) were retrospectively diagnosed with CKD stage 3 or higher. However, the review of the discharge reports found correct diagnosis of CKD in only 38.1 % (n = 43) of these patients.

Conclusions

The present analysis shows that CKD remains frequently unrecognized, even in a hospital setting. This could have dramatic implications on the care, treatment and prevention of CKD and associated complications.
Literatur
1.
Zurück zum Zitat Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–59.PubMedCrossRef Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–59.PubMedCrossRef
2.
Zurück zum Zitat White SL, Polkinghorne KR, Atkins RC, et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) Study GFR estimating equations: the AusDiab (Australian diabetes, obesity and lifestyle) Study. Am J Kidney Dis. 2010;55(4):660–70.PubMedCrossRef White SL, Polkinghorne KR, Atkins RC, et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) Study GFR estimating equations: the AusDiab (Australian diabetes, obesity and lifestyle) Study. Am J Kidney Dis. 2010;55(4):660–70.PubMedCrossRef
3.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.PubMedCrossRef Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.PubMedCrossRef
4.
Zurück zum Zitat OʼHare AM, Kaufman JS, Covinsky KE, et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Internal Med. 2009;150(10):717–24.CrossRef OʼHare AM, Kaufman JS, Covinsky KE, et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Internal Med. 2009;150(10):717–24.CrossRef
5.
Zurück zum Zitat Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44(2):198–206.PubMedCrossRef Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44(2):198–206.PubMedCrossRef
6.
Zurück zum Zitat Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Internal Med. 2004;164(6):659–63.CrossRef Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Internal Med. 2004;164(6):659–63.CrossRef
7.
Zurück zum Zitat Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–47.PubMedCrossRef Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034–47.PubMedCrossRef
8.
Zurück zum Zitat Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.PubMedCrossRef Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.PubMedCrossRef
9.
Zurück zum Zitat Anandarajah S, Tai T, de Lusignan S, et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrol Dial Transplant. 2005;20(10):2089–96.PubMedCrossRef Anandarajah S, Tai T, de Lusignan S, et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrol Dial Transplant. 2005;20(10):2089–96.PubMedCrossRef
10.
Zurück zum Zitat Middleton RJ, Foley RN, Hegarty J, et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant. 2006;21(1):88–92.PubMedCrossRef Middleton RJ, Foley RN, Hegarty J, et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant. 2006;21(1):88–92.PubMedCrossRef
11.
Zurück zum Zitat Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736–41.PubMedCrossRef Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736–41.PubMedCrossRef
12.
Zurück zum Zitat Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998–1999. J Am Soc Nephrol. 2005;16(2):489–95.PubMedCrossRef Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998–1999. J Am Soc Nephrol. 2005;16(2):489–95.PubMedCrossRef
13.
Zurück zum Zitat Kerr M, Bray B, Medcalf J, et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73–iii80.PubMedCrossRef Kerr M, Bray B, Medcalf J, et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73–iii80.PubMedCrossRef
14.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group. Ann Internal Med. 1999;130(6):461–70.CrossRef Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. modification of diet in renal disease study group. Ann Internal Med. 1999;130(6):461–70.CrossRef
15.
Zurück zum Zitat Ferris M, Shoham DA, Pierre-Louis M, et al. High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital. Am J Med Sci. 2009;337(2):93–7.PubMedCrossRef Ferris M, Shoham DA, Pierre-Louis M, et al. High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital. Am J Med Sci. 2009;337(2):93–7.PubMedCrossRef
16.
Zurück zum Zitat Gentile G, Postorino M, Mooring RD, et al. Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital. BMC Nephrol. 2009;10:24.PubMedCrossRef Gentile G, Postorino M, Mooring RD, et al. Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital. BMC Nephrol. 2009;10:24.PubMedCrossRef
17.
Zurück zum Zitat Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis. 2008;52(3):444–53.PubMedCrossRef Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis. 2008;52(3):444–53.PubMedCrossRef
18.
19.
Zurück zum Zitat Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.PubMed Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.PubMed
20.
Zurück zum Zitat Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31–8.PubMedCrossRef Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31–8.PubMedCrossRef
21.
Zurück zum Zitat KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2012;3(Suppl 1):1–150. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2012;3(Suppl 1):1–150.
22.
Zurück zum Zitat Kramar R, Oberbauer R. Austrian Dialysis and Transplantation Registry (OEDTR), Annual Report 2011. Austrian Society of Nephrology; 2011. Kramar R, Oberbauer R. Austrian Dialysis and Transplantation Registry (OEDTR), Annual Report 2011. Austrian Society of Nephrology; 2011.
23.
Zurück zum Zitat Grassmann A, Gioberge S, Moeller S, et al. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–93.PubMedCrossRef Grassmann A, Gioberge S, Moeller S, et al. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–93.PubMedCrossRef
24.
Zurück zum Zitat Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(Suppl 1):S37–40.PubMed Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(Suppl 1):S37–40.PubMed
25.
Zurück zum Zitat Matzke GR, Aronoff GR, Atkinson AJ Jr., et al. Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(11):1122–37.PubMedCrossRef Matzke GR, Aronoff GR, Atkinson AJ Jr., et al. Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(11):1122–37.PubMedCrossRef
26.
Zurück zum Zitat Hug BL, Witkowski DJ, Sox CM, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8.PubMedCrossRef Hug BL, Witkowski DJ, Sox CM, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8.PubMedCrossRef
27.
Zurück zum Zitat Akbari A, Grimshaw J, Stacey D, et al. Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate. CMAJ. 2012;184(5):E269–E76.PubMed Akbari A, Grimshaw J, Stacey D, et al. Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate. CMAJ. 2012;184(5):E269–E76.PubMed
28.
Zurück zum Zitat Hobbs H, Stevens P, Klebe B, et al. Referral patterns to renal services: what has changed in the past 4 years? Nephrol Dial Transplant. 2009;24(11):3411–9.PubMedCrossRef Hobbs H, Stevens P, Klebe B, et al. Referral patterns to renal services: what has changed in the past 4 years? Nephrol Dial Transplant. 2009;24(11):3411–9.PubMedCrossRef
29.
Zurück zum Zitat National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.CrossRef National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.CrossRef
30.
Zurück zum Zitat Poggio ED, Nef PC, Wang X, et al. Performance of the Cockcroft—Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis. 2005;46(2):242–52.PubMedCrossRef Poggio ED, Nef PC, Wang X, et al. Performance of the Cockcroft—Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis. 2005;46(2):242–52.PubMedCrossRef
31.
Zurück zum Zitat Newhouse JH, Kho D, Rao QA, et al. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR. 2008;191(2):376–82.PubMedCrossRef Newhouse JH, Kho D, Rao QA, et al. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR. 2008;191(2):376–82.PubMedCrossRef
32.
Zurück zum Zitat Kurtal H, Schwenger V, Azzaro M, et al. Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology. 2009;55(3):288–95.PubMedCrossRef Kurtal H, Schwenger V, Azzaro M, et al. Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology. 2009;55(3):288–95.PubMedCrossRef
Metadaten
Titel
Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture
verfasst von
Claudia Friedl
Margit Hemetsberger
Julia Mader
Astrid Fahrleitner-Pammer
Thomas R. Pieber
Alexander R. Rosenkranz
Publikationsdatum
01.07.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0374-7

Weitere Artikel der Ausgabe 13-14/2013

Wiener klinische Wochenschrift 13-14/2013 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Preisverleihung